Showing results (151-160 of 255) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2020
Swab-Yourself Trial With Economic Monitoring and Testing for Infections Collectively (SYSTEMATIC): Part 2. A Diagnostic Accuracy and Cost-effectiveness Study Comparing Rectal, Pharyngeal, and Urogenital Samples Analyzed Individually, Versus as a Pooled Specimen, for the Diagnosis of Gonorrhea and ChlamydiaJanet D Wilson, Harriet E Wallace, Michelle Loftus-Keeling, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
Microbial Biotechnology|April 10, 2023
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosisWilliam A Davis Birch, Ines B Moura, Duncan J Ewin, et al.
Sexually Transmitted Diseases|June 10, 2021
Utility of Whole Genome Sequencing in Assessing and Enhancing Partner Notification of Neisseria gonorrhoeae InfectionLing Yuan Kong, Janet D Wilson, Ines B Moura, et al.
Infection Control and Hospital Epidemiology|March 24, 2010
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)Stuart H Cohen, Dale N Gerding, Stuart Johnson, et al.
Anaerobe|December 18, 2019
Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencingZhen Zeng, Hailong Zhao, Mary Beth Dorr, et al.
International Journal of Antimicrobial Agents|February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trialsG Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 29, 2019
Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY IIEllie J C Goldstein, Diane M Citron, Dale N Gerding, et al.
Emerging Infectious Diseases|September 18, 2020
Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, SwitzerlandAndreas F Widmer, Reno Frei, Ed J Kuijper, et al.
Emerging Microbes & Infections|June 11, 2020
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional studyMasoumeh Azimirad, Marcela Krutova, Abbas Yadegar, et al.
Pageof 26